Bentracimab Reverses Ticagrelor Effects in Phase 3 Trial
SFJ Pharmaceuticals and SERB Pharmaceuticals announced positive final results from the Phase 3 REVERSE-IT trial of bentracimab, a ticagrelor...
eClinical Tech News
Vaxcyte Announces Positive VAX-24 Infant Phase 2 Results
Vaxcyte, a clinical-stage vaccine company, will present topline results from its Phase 2 infant study of VAX-24, a 24-valent...
Promising Early Data from NBTXR3 Phase 1 Study in Advanced NSCLC
Nanobiotix announced positive Phase 1 data for NBTXR3 (JNJ-1900), a radiotherapy-activated nanoparticle therapy, in patients with locally advanced non-small...
Promising Portage Biotech Preclinical Results Support Trial
Portage Biotech presented preclinical data for PORT-7 (TT-4), a selective A2B adenosine receptor inhibitor, at the 2025 European Lung...
Chemomab’s PSC Trial Shows Positive Liver Biomarker Results
Chemomab Therapeutics announced positive 48-week data from the open-label extension (OLE) of its Phase 2 SPRING trial for nebokitug...
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2a Trial of CAN-2409 in Advanced NSCLC
Candel Therapeutics announced final survival data from a Phase 2a clinical trial of CAN-2409 in patients with advanced non-small...
Rani Therapeutics Announces Bioequivalence of Oral GLP-1/GLP-2 Dual Agonist RT-114
Rani Therapeutics announced positive preclinical data for RT-114, an oral formulation of ProGen’s GLP-1/GLP-2 dual agonist, PG-102, for obesity...
Sonnet Biotherapeutics’ SON-1010 Shows Promising Safety in Sarcoma Combination Trial
Sonnet BioTherapeutics announced positive safety data from an expansion cohort of its Phase 1 SB101 trial. The trial is...
Decoy Therapeutics’ Novel Inhibitors Show Promise Against Measles
Decoy Therapeutics, a preclinical biopharmaceutical company, has announced that its antiviral drug candidates, designed using its IMP3ACT™ platform, have...
Acu193 Alzheimer’s Trial Enrollment Complete
Acumen Pharmaceuticals has completed enrollment in its Phase 2 ALTITUDE-AD trial of sabirnetug (ACU193) for early-stage Alzheimer’s diseaseAlzheimer’s disease....